These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28906371)

  • 21. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.
    Shao GL; Zheng JP; Guo LW; Chen YT; Zeng H; Yao Z
    Medicine (Baltimore); 2017 Jan; 96(3):e5518. PubMed ID: 28099329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study.
    Ren ZG; Lin ZY; Xia JL; Ye SL; Ma ZC; Ye QH; Qin LX; Wu ZQ; Fan J; Tang ZY
    World J Gastroenterol; 2004 Oct; 10(19):2791-4. PubMed ID: 15334671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.
    Mano Y; Shirabe K; Yamashita Y; Harimoto N; Tsujita E; Takeishi K; Aishima S; Ikegami T; Yoshizumi T; Yamanaka T; Maehara Y
    Ann Surg; 2013 Aug; 258(2):301-5. PubMed ID: 23774313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
    Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
    Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.
    Zhao WC; Fan LF; Yang N; Zhang HB; Chen BD; Yang GS
    Eur J Surg Oncol; 2013 Aug; 39(8):858-64. PubMed ID: 23669199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
    Liu KJ; Lv YX; Niu YM; Bu Y
    Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
    Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
    JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Analysis of Hepatocellular Carcinoma With Hepatitis C Virus Infection Using Epithelial-Mesenchymal Transition Gene Profiles.
    Ueno M; Kawai M; Park JY; Hirono S; Okada KI; Hayami S; Wang HJ; Yamaue H
    J Surg Res; 2020 Jan; 245():302-308. PubMed ID: 31421377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma.
    Feng LH; Dong H; Lau WY; Yu H; Zhu YY; Zhao Y; Lin YX; Chen J; Wu MC; Cong WM
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):293-303. PubMed ID: 27743138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience.
    Schlichtemeier SM; Pang TC; Williams NE; Gill AJ; Smith RC; Samra JS; Lam VW; Hollands M; Richardson AJ; Pleass HC; Nozawa S; Albania M; Hugh TJ
    Eur J Surg Oncol; 2016 Oct; 42(10):1576-83. PubMed ID: 27378158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
    Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria.
    Li C; Wen TF; Yan LN; Lu WS; Li B; Wang WT; Xu MQ; Yang JY
    J Surg Res; 2017 Mar; 209():8-16. PubMed ID: 28032575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
    Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study.
    Wang ZX; Wang EX; Bai W; Xia DD; Mu W; Li J; Yang QY; Huang M; Xu GH; Sun JH; Li HL; Zhao H; Wu JB; Yang SF; Li JP; Li ZX; Zhang CQ; Zhu XL; Zheng YB; Wang QH; Li J; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH; On Behalf Of China Hcc-Tace Study Group
    World J Gastroenterol; 2020 Feb; 26(6):657-669. PubMed ID: 32103874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
    Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
    Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center.
    Xu L; Li L; Wang P; Zhang M; Zhang Y; Hao X; Yan L; Li B; Wen T; Xu M
    Gut Liver; 2019 Nov; 13(6):669-682. PubMed ID: 30970430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.
    Shim JH; Jun MJ; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC
    Ann Surg; 2015 May; 261(5):939-46. PubMed ID: 24950276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.